A new method of estimating prevalence of childhood cancer survivors (POCCS): example of the 20-year prevalence in The Netherlands
Author:
Gini Andrea1ORCID, Colombet Murielle1, de Paula Silva Neimar1, Visser Otto2, Youlden Danny3, Soerjomataram Isabelle1, Stiller Charles A4, Steliarova-Foucher Eva1, Dolya Anastasia, Gini AndreaORCID, Stiller Charles, Kuehni Claudia, Youlden Danny, Heenen Delphine, Steliarova-Foucher Eva, Bray Freddie, Erdmann Friederike, Soerjomataram Isabelle, Winther Jeanette Falck, Aitken Joanne, Pritchard-Jones Kathy, Hjorth Lars, Piñeros Marion, Colombet Murielle, de Paula Silva Neimar, Sherwood Sarah, Tomášiková Zuzana,
Affiliation:
1. Cancer Surveillance Branch, International Agency for Research on Cancer (IARC) , Lyon, France 2. Netherlands Comprehensive Cancer Organisation (IKNL) , Utrecht, The Netherlands 3. Viertel Cancer Research Centre, Cancer Council Queensland , Brisbane, Australia 4. National Cancer Registration and Analysis Service, NHS Digital , Didcot, UK
Abstract
Abstract
Background
Estimating the number of childhood cancer survivors is crucial for cancer control, including clinical guidelines. To compare estimates across countries despite data sharing restrictions, we propose a new method of computing limited-duration prevalence of childhood cancer survivors (POCCS) using aggregated data.
Methods
We developed a Markov model that simulates, for each calendar year and birth cohort in a population, the proportion of individuals in the following health states: healthy, newly diagnosed with cancer, surviving with cancer, and deceased. Transitions between health states were informed using annual sex- and age-specific incidence rates, conditional 1-year net survival probabilities from the Netherlands Cancer Registry (1989–2011), and annual mortality probability by sex and age group for The Netherlands from the Human Mortality Database. Applying a Markov model, we computed 20-year prevalence of childhood cancer survivors. The resulting POCCS estimates, stratified by sex, were compared with SEER*Stat estimates derived from individual cancer records from the same registry.
Results
In 2011, POCCS predicted 654 males [95% confidence interval (95% CI): 637–672] and 539 females (95% CI: 523–555) per million persons living in The Netherlands after childhood cancer diagnosed within the previous 20 years. Using SEER*Stat, the 20-year prevalence was 665 males (95% CI: 647–683) and 544 females (95% CI: 529–560) per million persons on 1 July 2011.
Conclusions
Using the POCCS model and aggregated cancer data, our estimates of childhood cancer survivors limited-duration prevalence were consistent with those computed by a standard method requiring individual cancer records. The POCCS method provides relevant information for planning follow-up and care for childhood cancer survivors.
Funder
Children with Cancer UK
Publisher
Oxford University Press (OUP)
Subject
General Medicine,Epidemiology
Reference32 articles.
1. Childhood cancer survival in Europe 1999-2007: results of EUROCARE: a population-based study;Gatta;Lancet Oncol,2014 2. Survivorship after childhood cancer: PanCare: a European Network to promote optimal long-term care;Hjorth;Eur J Cancer,2015 3. Survivors of childhood cancer in the United States: prevalence and burden of morbidity;Phillips;Cancer Epidemiol Biomarkers Prev,2015 4. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study;Armstrong;J Clin Oncol,2014 5. The European multistakeholder PanCareFollowUp project: novel, person-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for cancer survivors and caregivers;van Kalsbeek;Eur J Cancer,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|